Improving Type 2 Diabetes Therapy Adherence and Persistence in GermanyTim Borgas
Part of a 6 paper series on how to address avoidable economic and societal burden of T2D in Germany, the UK, the US, Mexico, Brazil and Saudi Arabia. Published by the IMS Institute under: http://www.imshealth.com/en/thought-leadership/ims-institute/reports/diabetes-series
Improving Type 2 Diabetes Therapy Adherence and Persistence in GermanyTim Borgas
Part of a 6 paper series on how to address avoidable economic and societal burden of T2D in Germany, the UK, the US, Mexico, Brazil and Saudi Arabia. Published by the IMS Institute under: http://www.imshealth.com/en/thought-leadership/ims-institute/reports/diabetes-series